Cite
HARVARD Citation
Nixon, N. et al. (2018). A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer. European journal of cancer. pp. 72-81. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nixon, N. et al. (2018). A review of the value of human epidermal growth factor receptor 2 (HER2)-targeted therapies in breast cancer. European journal of cancer. pp. 72-81. [Online].